Price loading...

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Immunology Therapeutics in China
98% match

The 2023-2028 Outlook for Immunology Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
97% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Kinase Inhibitors in China
97% match

The 2023-2028 Outlook for Kinase Inhibitors in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Nutraceuticals in China
97% match

The 2023-2028 Outlook for Nutraceuticals in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Immunology Drugs in China
97% match

The 2023-2028 Outlook for Immunology Drugs in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 08 Mar 2026
The 2023-2028 Outlook for Immunology in China
97% match

The 2023-2028 Outlook for Immunology in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in China
96% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in China
96% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in China

£495.00 24 Feb 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
96% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in China
96% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Digital Therapeutic (DTx) in China
96% match

The 2023-2028 Outlook for Digital Therapeutic (DTx) in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in China
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in China
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Life Science Products in China
96% match

The 2023-2028 Outlook for Life Science Products in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for COVID-19 Vaccines in China
96% match

The 2023-2028 Outlook for COVID-19 Vaccines in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in China
96% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in China

£495.00 24 Jan 2026